Foley attorney Sarah Key authored an article titled “Glaxo’s big, fat attack on dietary supplements” in the August 11, 2008 issue of the National Law Journal. The article addresses the regulatory and constitutional implications of a citizen petition submitted to the U.S. Food and Drug Administration by GlaxoSmithKline. The petition calls for the FDA to prohibit “structure/function” claims for dietary supplements that expressly or impliedly reference weight loss.
Related News
December 12, 2025
In the News
Foley Chairman and CEO Daljit Doogal Talks Firm Strategy and Growth, Featured in Media for Reelection
Foley & Lardner LLP Chairman and CEO Daljit Doogal is featured in The American Lawyer article, “Foley Board Taps Daljit Doogal for Second Term as Chair and CEO,” for his reelection to a second four-year term.
December 11, 2025
In the News
Carrie Hoffman Comments on SCOTUS Arbitration Jurisdiction Case
Foley & Lardner LLP partner Carrie Hoffman commented on the U.S. Supreme Court's decision to hear an arbitration jurisdiction case in the Law360 article, "High Court Arb. Jurisdiction Case May Impact W&H Cases."
December 10, 2025
In the News
Charles Gass Quoted on Health Care Implications of Colorado AI Act
Foley & Lardner LLP senior counsel Charles Gass detailed Colorado's Artificial Intelligence Act and its implications for health providers in the ColoradoBiz article, “Colorado leads nation on AI healthcare regulations.”